Saponin treatment also enhanced the activation and expression of TREM2 and IDE in a dose-dependent manner and affected the expression of inflammatory genes and cytokines involved in AD worsening (i.e., NF-kB and IL-1B). This evidence concerns the gene NFKB1 and Alzheimer disease.